Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women

PHASE2CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Overactive Bladder
Interventions
DRUG

Tolterodine tartrate extended release capsules

DRUG

Desmopressin orally disintegrating tablets

DRUG

Placebo orally disintegrating tablets

Trial Locations (24)

Unknown

NEA Baptist Clinic, Jonesboro

Lynn Institute of The Ozarks, Little Rock

Moez Khorsandi, DO, Los Angeles

Urology Group of Southern California, Los Angeles

Riverside Clinical Research, Edgewater

Health Awareness, Inc., Jupiter

Pines Clinical Research, Inc., Pembroke Pines

Palm Beach Research Center, West Palm Beach

Clinical Research Atlanta, Stockbridge

Northshore Center for Gastroenterology, Evanston

Remedica, LLC, Rochester

The Urological Institute of Northeastern New York, Albany

Premier Medical Group of the Hudson Valley, P.C., Poughkeepsie

Parkhurst Research Organization, LLC, Bethany

Philadelphia Clinical Research, LLC, Philadelphia

Medical University of South Carolina, Charleston

Coastal Carolina Research Center, Mt. Pleasant

Vanderbilt University Medical Center, Nashville

Research Across America, Dallas

Advances in Health, Houston

Pioneer Research Solutions, Inc., Houston

Radiant Research, San Antonio

Clinical Research Associates of Tidewater, Norfolk

Seattle Women's: Health, Research, Gynecology, Seattle

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY